Annual Total Liabilities
$180.70 K
-$14.59 M-98.78%
June 30, 2024
Summary
- As of February 22, 2025, ESLA annual total liabilities is $180.70 thousand, with the most recent change of -$14.59 million (-98.78%) on June 30, 2024.
- During the last 3 years, ESLA annual total liabilities has risen by +$180.70 thousand (+100.00%).
- ESLA annual total liabilities is now -98.78% below its all-time high of $14.77 million, reached on June 1, 2023.
Performance
ESLA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$2.99 M
+$2.81 M+1554.07%
September 30, 2024
Summary
- As of February 22, 2025, ESLA quarterly total liabilities is $2.99 million, with the most recent change of +$2.81 million (+1554.07%) on September 30, 2024.
- Over the past year, ESLA quarterly total liabilities has increased by +$2.59 million (+649.66%).
- ESLA quarterly total liabilities is now -82.70% below its all-time high of $17.28 million, reached on September 30, 2023.
Performance
ESLA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ESLA Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -98.8% | +649.7% |
| 3 y3 years | +100.0% | - |
| 5 y5 years | +100.0% | - |
ESLA Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -98.8% | -100.0% | -82.7% | +2058.1% |
| 5 y | 5-year | -98.8% | -100.0% | -82.7% | +2058.1% |
| alltime | all time | -98.8% | -100.0% | -82.7% | +2058.1% |
Estrella Immunopharma Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.99 M(+1554.1%) |
| Jun 2024 | $180.70 K | $180.70 K(+30.5%) |
| Mar 2024 | - | $138.50 K(-65.3%) |
| Dec 2023 | - | $398.70 K(-97.7%) |
| Sep 2023 | - | $17.28 M(+17.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $14.77 M(+55.0%) |
| Jun 2023 | $14.77 M(+147.8%) | - |
| Dec 2022 | - | $9.53 M |
| Jun 2022 | $5.96 M(>+9900.0%) | - |
| Jun 2021 | $0.00 | - |
FAQ
- What is Estrella Immunopharma annual total liabilities?
- What is the all time high annual total liabilities for Estrella Immunopharma?
- What is Estrella Immunopharma annual total liabilities year-on-year change?
- What is Estrella Immunopharma quarterly total liabilities?
- What is the all time high quarterly total liabilities for Estrella Immunopharma?
- What is Estrella Immunopharma quarterly total liabilities year-on-year change?
What is Estrella Immunopharma annual total liabilities?
The current annual total liabilities of ESLA is $180.70 K
What is the all time high annual total liabilities for Estrella Immunopharma?
Estrella Immunopharma all-time high annual total liabilities is $14.77 M
What is Estrella Immunopharma annual total liabilities year-on-year change?
Over the past year, ESLA annual total liabilities has changed by -$14.59 M (-98.78%)
What is Estrella Immunopharma quarterly total liabilities?
The current quarterly total liabilities of ESLA is $2.99 M
What is the all time high quarterly total liabilities for Estrella Immunopharma?
Estrella Immunopharma all-time high quarterly total liabilities is $17.28 M
What is Estrella Immunopharma quarterly total liabilities year-on-year change?
Over the past year, ESLA quarterly total liabilities has changed by +$2.59 M (+649.66%)